Stifel analysts maintained a positive outlook on MaxLinear shares (NASDAQ:MXL), reiterating a Buy rating and a price target ...
Stifel analysts reiterated a Buy rating on Bicara Therapeutics Inc (NASDAQ:BCAX), maintaining a $47.00 price target. Trading ...
Stifel Nicolaus analyst Stephen Willey maintained a Hold rating on Exelixis (EXEL – Research Report) today and set a price target of $30.00.
The race for AI supremacy has taken an unexpected twist as Chinese AI startup DeepSeek’s latest AI model, which is both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback